US4443446A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Use of psychoactive drugs as vaginal contraceptives
Assignee: University of Georgia Research Foundation Inc
•
Filing: 1980-05-30
•
Granted: 1984-04-17
•
Expires: 2000-05-30
Abstract
Abstract The use of psychoactive drugs as vaginal contraceptives is disclosed. The invention may be implemented by incorporating a psychoactive drug in a known method such as jelly, foam, or suppository introduction means prior to intercourse. Furthermore, the use of psychoactive drugs after intercourse using the above methods is disclosed.
Inventors
- 👤 Milton J. Cormier
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-05 17:41
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/13; A61K31/135; A61K31/33; A61K31/395; A61K31/435; A61K31/44; A61K31/445; A61K31/55; A61K9/00; A61K9/0012; A61K9/0034; Y; Y10; Y10S; Y10S424/00; Y10S424/14
Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
40 words
A method for preventing conception in a female which comprises: introducing an effective amount of a calmodulin binding psychoactive drug selected from the group consisting of penfluridol, pimozide, trifluoperazine, chlorpromazine, benperidol, haloperidol, and clozapine into the vagina of the female.
Claim 2
Independent Claim
40 words
A method for preventing conception in a female which comprises: introducing an effective amount of a calmodulin binding psychoactive drug selected from the group consisting of penfluridol, pimozide, trifluoperazine, chlorpromazine, benperidol, haloperidol, and clozapine into the vagina of the female.
Claim 3
Dependent Claim
47 words
The method as described in claim 1 wherein the introduction of said pschoactive drug comprises the steps of: introducing said psychoactive drug into the vagina of the female prior to sexual intercourse; and allowing said psychoactive drug to remain in the vagina during and after sexual intercourse.
Claim 4
Dependent Claim
40 words
The method described in claim 2, wherein the step of introducing said psychoactive drug comprises introducing a mixture of said psychoactive drug and a foam carrier into the vagina of the female prior to sexual intercourse by foam injection means.
Claim 5
Dependent Claim
41 words
The method as described in claim 2, wherein the step of introducing said psychoactive drug comprises introducing a mixture of said psychoactive drug and a jelly carrier into the vagina of the female prior to sexual intercourse by jelly insertion means.
Claim 6
Dependent Claim
22 words
The method as described in claim 2, wherein said psychoactive drug is introduced into the vagina of the female by suppository means.
Claim 7
Dependent Claim
25 words
The method as described in claim 1 wherein the introduction of said psychoactive drug comprises: introducing said psychoactive drug into the vagina after sexual intercourse.
Claim 8
Dependent Claim
30 words
The method as described in claim 6, wherein the step of introducing said psychoactive drug comprises introducing a mixture of said psychoactive drug and a suitable carrier into the vagina.
Claim 9
Independent Claim
31 words
The method as described by claims 1, 2, 3, 4, 5, 6, or 7, wherein the amount of the psychoactive drug introduced into the vagina is about 10 milligrams or greater.
Claim 10
Dependent Claim
46 words
A contraceptive composition comprising an effective amount of a psychoactive drug selected from the group consisting of penfluridol, pimozide, trifluoperazine, chlorprothixene, thioridazine, chlorpromazine, benperidol, haloperidol, and clozapine; and a suitable vaginal carrier medium selected from the group consisting of jelly carriers, foam carriers and suppository carriers.
Claim 11
Dependent Claim
46 words
A contraceptive composition comprising an effective amount of a psychoactive drug selected from the group consisting of penfluridol, pimozide, trifluoperazine, chlorprothixene, thioridazine, chlorpromazine, benperidol, haloperidol, and clozapine; and a suitable vaginal carrier medium selected from the group consisting of jelly carriers, foam carriers and suppository carriers.
Claim 12
Dependent Claim
28 words
The composition as described in claim 9, wherein the concentration of said psychoactive drug is equal to or greater than 5 milligrams per milliliter of said carrier medium.
References Cited (Backward Citations)
US2541103A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1987-04-17 | 1987-10-17 | 1988-04-17 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1991-04-17 | 1991-10-17 | 1992-04-17 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1995-04-17 | 1995-10-17 | 1996-04-17 | $7700.00 | Window Closed / Lapsed |